April 6, 2007 — MedicalCV Inc., Minneapolis, MN, has announced that Allen R. Raczkowski, M.D., director of Robotic Cardiac Surgery at Banner Baywood Health Systems in Mesa, AZ, performed a closed-chest, robotic, lone cardiac ablation procedure on an arrested heart on March 30 using the ATRILAZE Surgical Ablation System.

April 6, 2007 — Spectranetics Corp., Colorado Springs, CO, has announced the commercial availability of the TURBO elite product line for excimer laser ablation to treat peripheral artery disease (PAD). The TURBO elite product line features an enhanced outer jacket and inner guide wire lumen with optimized ablation efficiency and energy output that enables increased penetration rates.

The AXIOM Sensis XP combines both hemo and advanced EP applications in one system. The system delivers clinical workflow support programs that are flexible and customizable. Reports are generated automatically, based on customizable templates, integrating database entries and key images. High signal quality means diagnostic confidence during procedures.

The AXIOM Sensis XP combines both hemo and advanced EP applications in one system. The system delivers clinical workflow support programs that are flexible and customizable. Reports are generated automatically, based on customizable templates, integrating database entries and key images. High signal quality means diagnostic confidence during procedures.

April 4, 2007 — Immersion Medical has updated its endovascular platform with features that allow it to simulate a wider range of procedures. The new platform, now called the CathLabVR system, allows surgical simulation with as many as four devices or tools and for procedures involving more regions of the body.

In addition to coronary treatments, physicians use endovascular procedures to treat several other diseases, including peripheral arterial disease.

Cardica Inc. has announced that it has received FDA 510(k) clearance to market its C-Port Flex A Anastomosis System in the U.S. The Flex A is a variation of Cardica's C-Port xA Distal Anastomosis System product line and further facilitates the automated anastomosis, or attachment of blood vessels and grafts, during less invasive coronary artery bypass graft (CABG) procedures.

April 4, 2007 — Stereotaxis, Inc. has announced that its partnered magnetically enabled 8mm ablation catheter has received FDA approval and will soon be commercially available in the U.S.

Two leading European electrophysiology centers have been building successful clinical experience using this catheter to treat atrial cardiac arrhythmias.

April 4, 2007 — Vital Images, Inc., a leading provider of enterprise-wide advanced visualization and analysis software, and Toshiba Medical Systems Corp. have agreed to renew their U.S. and international marketing and distribution agreement for two years, through December 31, 2008.

April 4, 2007 — Volcano Corp. and ev3 Inc. have announced they have entered into a joint marketing and distribution agreement.

Under the terms of the agreement, Volcano will have the opportunity to sell ev3’s SpiderFX Embolic Protection Device in conjunction with its Intravascular Ultrasound (IVUS) and Functional Measurement (FM) devices for use in saphenous vein grafts (SVGs) in the U.S. The SpiderFX is FDA cleared for use during the endovascular treatment of both SVGs and carotid arteries.

April 4, 2007 — A Japanese study has shown that people who take statins and also consume omega-3 fatty acids, typically found in fish and fish oil, have a better chance of avoiding heart problems than patients who take statins alone. The “Japan EPA Lipids Intervention Study” was published in the March 31 issue of The Lancet.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now